Phosphorus-31 nuclear magnetic resonance study of the effect of pentachlorophenol (PCP) on the physiologies of PCP-degrading microorganisms.
Free and agarose-encapsulated pentachlorophenol (PCP)-degrading Sphingomonas sp. isolates UG25 and UG30 were compared to Sphingomonas chlorophenolica ATCC 39723 with respect to the ability to degrade PCP. Pretreatment of the UG25 and UG30 strains with 50 microg of PCP per ml enabled the cells to subsequently degrade higher levels of this environmental pollutant. Similar treatment of ATCC 39723 cells had no effect on the level of PCP degraded by this strain. Phosphorus-31 nuclear magnetic resonance spectra of agarose-immobilized strains UG25 and UG30 grown in the absence of PCP showed that there was marked deenergization of the cells upon exposure to a nonlethal concentration of PCP (120 microg/ml). For example, no transmembrane pH gradient was observed, and the ATP levels were lower than the levels obtained in the absence of PCP. The transmembrane pH gradient and ATP levels were restored once the immobilized cells had almost completely degraded the PCP in the perfusion medium. PCP-pretreated cells, on the other hand, maintained their transmembrane pH gradient and ATP levels even in the presence of high levels of PCP. The ability of PCP-pretreated strain UG25 and UG30 cells to remain energized in the presence of PCP was shown to correlate with an altered membrane phospholipid profile; these cells had a higher concentration of cardiolipin than cells cultured in the absence of PCP. Strain ATCC 39723, which did not degrade higher levels of PCP after PCP pretreatment, did not show this response.
Lohmeier-Vogel
E M
EM
Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada T2N 1N4. lohmeier@ucalgary.ca
Leung
K T
KT
Lee
H
H
Trevors
J T
JT
Vogel
H J
HJ
D001673:Biodegradation, Environmental; D018914:Cells, Immobilized; D009682:Magnetic Resonance Spectroscopy; D008566:Membranes / Q000737:chemistry; D010101:Oxygen Consumption; D010416:Pentachlorophenol / Q000378:metabolism* / Q000494:pharmacology*; D010743:Phospholipids / Q000032:analysis; D010759:Phosphorus Isotopes / Q000378:metabolism; D020578:Sphingomonas / Q000187:drug effects* / Q000502:physiology*
D010743:Phospholipids; D010759:Phosphorus Isotopes; D010416:Pentachlorophenol